Pharmacokinetics and Pharmacodynamics Specialists analyze the processes that govern the movement of drugs within the body and their interactions with biological systems. Pharmacokinetics (PK) focuses on how the body absorbs, distributes, metabolizes, and eliminates drugs. It helps determine the right dosage and timing for medications to achieve therapeutic effects without causing harm. On the other hand, pharmacodynamics (PD) examines the relationship between drug concentration at the site of action and the resulting effects on the body, including efficacy and potential side effects. These specialists play a crucial role in optimizing drug therapy by ensuring that drugs are used safely and effectively across different populations. Their expertise also aids in the development of new drug delivery systems that improve drug bioavailability and therapeutic outcomes.
Pharmacologists, clinicians, and drug developers throughout the drug development process. They conduct studies to understand the drug's behavior in the body, ensuring it reaches the target site in the appropriate amount and at the right time. Pharmacokinetics and pharmacodynamics specialists are also involved in predicting drug-drug interactions and personalizing treatments based on individual genetic, metabolic, and physiological factors. Their research ensures the safe and effective use of drugs in clinical settings, contributing to the ongoing development of new therapies for a wide range of conditions.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico